Elamipretide (SS-31)
ExperimentalClinical trial / Longevity research
Mitochondria-targeted tetrapeptide (SS-31) investigated for mitochondrial dysfunction conditions.
For research use only.
Key Facts
- CAS
- 93479-97-1
- Molecular Weight (MW)
- 627.8 g/mol
- Half-life
- ~4–5 h (iv) in human studies
- Unit
- mcg
- Administration Route
- IV / SC (investigational)
- Frequency
- —
- Last updated
- 12/14/2025
Overview
Mitochondria-targeted tetrapeptide (SS-31) investigated for mitochondrial dysfunction conditions.
Protocol
- Dosage Range
- Per trial protocol
- Frequency
- —
- Cycle
- —
- Administration Route
- IV / SC (investigational)
- Reconstitution Guide
- —
Science
Mechanism of Action
Mechanism of action not fully established in publicly available sources.
Studies are being curated for this entry.
Suggest a studyBenefits
Therapeutic benefits not fully established.
Potential Side Effects
- Side effects not fully established.